---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-067474"
form_type: "8-K"
ticker: "IXHL"
cik: "0001873875"
company_name: "Incannex Healthcare Inc."
filed_at: "2025-07-25T23:59:59+00:00"
generated_at: "2026-05-18T01:19:24.092423+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Incannex appoints Dr. Gamaldo to OSA advisory board; Phase 2 data due next week

## Summary
- Dr. Charlene E. Gamaldo (Johns Hopkins professor) joins IHL-42X Obstructive Sleep Apnea Clinical Advisory Board.
- Phase 2 data readout for IHL-42X expected next week, per CMO Dr. Lou Barbato.
- Gamaldo has joint appointments in neurology, psychiatry, nursing, anesthesiology, and public health.
- She has authored >120 scholarly works and received multiple sleep medicine leadership awards.
- Appointment reflects Incannex's growing confidence in IHL-42X and commitment to scientific rigor.

## SEC filing metadata
- accession: 0001213900-25-067474
- form_type: 8-K
- ticker: IXHL
- cik: 0001873875
- company_name: Incannex Healthcare Inc.
- filed_at: 2025-07-25T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873875/000121390025067474/0001213900-25-067474-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873875/000121390025067474/ea0250114-8k_incannex.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-067474
- JSON: https://secwatch.observer/filing/0001213900-25-067474.json
- Plain text: https://secwatch.observer/filing/0001213900-25-067474.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.